SCHEMBL2373449

SCHEMBL2373449

O=C(NCc1ccccc1)c1csc(Nc2ccccc2)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 4/20 0.57
MAPT P10636 4/20 0.57
LMNA P02545 2/20 0.57
MAPK1 P28482 1/20 0.57
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
ENPP2 Q13822 1/20 0.52
GAA P10253 3/20 0.51
CLK1 P49759 2/20 0.51
CLK4 Q9HAZ1 2/20 0.51
DYRK3 O43781 1/20 0.51
CLK2 P49760 1/20 0.51
DYRK1A Q13627 1/20 0.51
DYRK2 Q92630 1/20 0.51
DYRK1B Q9Y463 1/20 0.51
HPGD P15428 3/20 0.50
ALDH1A1 P00352 2/20 0.50
NAMPT P43490 1/20 0.50
ALOX15 P16050 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2373924 0.92 NAMPT (0.57) AMY1AMAPTLMNAMAPK1MEN1
SCHEMBL14214492 0.87 AMY1A (0.61) AMY1AMAPTLMNAMAPK1MEN1
SCHEMBL24180547 0.86 MAPT (0.49) AMY1AMAPTLMNAMAPK1MEN1
SCHEMBL13116110 0.85 AMY1A (0.58) AMY1AMAPTLMNAMAPK1MEN1
SCHEMBL31681834 0.84 NPC1 (0.51) MAPTLMNAMAPK1MEN1KMT2A
SCHEMBL2374694 0.84 NPC1 (0.51) MAPTLMNAMAPK1MEN1KMT2A
SCHEMBL29072859 0.81 MMP13 (0.48) LMNAMAPK1SMN1; SMN2ENPP2GAA
SCHEMBL2373447 0.81 SMN1; SMN2 (0.52) MEN1KMT2ASMN1; SMN2GAAHPGD
SCHEMBL669856 0.81 MMP13 (0.48) LMNAMAPK1SMN1; SMN2ENPP2GAA
SCHEMBL24138632 0.80 MAPT (0.62) MAPTLMNAMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12410397-B2 Methods of enhancing cell survival of stem cells THE SCRIPPS RESEARCH INSTITUTE (US) 2025-09-09 US disclosed
EP-4585589-A2 STEM CELL CULTURES The Scripps Research Institute (US) 2025-07-16 EP disclosed
EP-4296270-B1 A COMPOSITION COMPRISING STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2025-06-18 EP disclosed
EP-4296270-A2 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2023-12-27 EP disclosed
EP-3936508-B1 A COMPOSITION COMPRISING STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2023-12-06 EP disclosed
EP-4206319-A1 INDUCTION OF PLURIPOTENT CELLS The Scripps Research Institute (US) 2023-07-05 EP disclosed
EP-3235901-B1 INDUCTION OF PLURIPOTENT CELLS SCRIPPS RESEARCH INST (US) 2022-12-21 EP disclosed
EP-3936508-A1 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2022-01-12 EP disclosed
EP-3936508-A1 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2022-01-12 EP disclosed
US-20210403878-A1 INDUCTION OF PLURIPOTENT CELLS THE SCRIPPS RESEARCH INSTITUTE 2021-12-30 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
WO-2011047300-A1 INDUCTION OF PLURIPOTENT CELLS THE SCRIPPS RESEARCH INSTITUTE (US) 2011-04-21 WO disclosed
WO-2010065721-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294761-A1 STEM CELL CULTURES NES, CD44, MCL1 AMY1A 4578/4885MAPT 2774/4885LMNA 1812/4885
US-12410397-B2 Methods of enhancing cell survival of stem cells MCL1, BCL2, BCLAF1 AMY1A 4418/4885MAPT 4154/4885LMNA 656/4885
US-20110224233-A1 STEM CELL CULTURES NES, CD44, MCL1 AMY1A 4578/4885MAPT 2774/4885LMNA 1812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.